{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:38:56Z","timestamp":1773153536981,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.amjmed.2010.02.002","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T13:27:45Z","timestamp":1269955665000},"page":"S4-S15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Case Studies of Lower Respiratory Tract Infections: Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"123","author":[{"suffix":"Jr.","given":"Thomas M.","family":"File","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2010.02.002_bib1","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2010.02.002_bib3","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.294.21.2760","article-title":"Pneumonia in older adults: reversing the trend","volume":"294","author":"File","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2010.02.002_bib4","first-page":"1","article-title":"2006 National Hospital Discharge Survey","author":"DeFrances","year":"2008","journal-title":"Natl Health Stat Rep"},{"key":"10.1016\/j.amjmed.2010.02.002_bib5","first-page":"1","article-title":"Deaths: final data for 2005","volume":"56","author":"Kung","year":"2008","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.amjmed.2010.02.002_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.1997.00440360129015","article-title":"Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio","volume":"157","author":"Marston","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib7","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1378\/chest.125.6.2140","article-title":"Treatment costs of community-acquired pneumonia in an employed population","volume":"125","author":"Colice","year":"2004","journal-title":"Chest"},{"issue":"suppl 2","key":"10.1016\/j.amjmed.2010.02.002_bib8","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 3","key":"10.1016\/j.amjmed.2010.02.002_bib9","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/591394","article-title":"The pneumonia severity index: a decade after the initial derivation and validation","volume":"47","author":"Aujesky","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2010.02.002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/09031936.06.00062505","article-title":"Validation of a predictive rule for the management of community-acquired pneumonia","volume":"27","author":"Capelastegui","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2010.02.002_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.06-1426","article-title":"Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones","volume":"131","author":"Metersky","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2010.02.002_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/421497","article-title":"Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia","volume":"39","author":"Musher","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/345852","article-title":"Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain","volume":"36","author":"Gutierrez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.rcc.2004.10.007","article-title":"Tuberculosis: still overlooked as a cause of community-acquired pneumonia\u2014how not to miss it","volume":"11","author":"Kunimoto","year":"2005","journal-title":"Respir Care Clin North Am"},{"key":"10.1016\/j.amjmed.2010.02.002_bib18","first-page":"510","article-title":"Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP","volume":"10","author":"Nyamande","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/archinte.1989.00390060028006","article-title":"Unsuspected pulmonary tuberculosis in a community teaching hospital","volume":"149","author":"Counsell","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/518702","article-title":"Fluoroquinolones should not be the first-line antibiotics to treat community-acquired pneumonia in areas of tuberculosis endemicity","volume":"45","author":"Singh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/thx.2005.056887","article-title":"Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas","volume":"61","author":"Wang","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2010.02.002_bib22","first-page":"747","article-title":"Fluoroquinolones may delay the diagnosis of tuberculosis","volume":"47","author":"Ang","year":"2006","journal-title":"Singapore Med J"},{"key":"10.1016\/j.amjmed.2010.02.002_bib23","first-page":"1215","article-title":"Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia","volume":"9","author":"Yoon","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejim.2006.02.016","article-title":"Can the routine use of fluoroquinolones for community-acquired pneumonia delay the diagnosis of tuberculosis?","volume":"17","author":"Avnon","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MAJ.0b013e3180a5e8ff","article-title":"Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case","volume":"335","author":"Grupper","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2010.02.002_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/340618","article-title":"Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis","volume":"34","author":"Dooley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/379328","article-title":"Fluoroquinolone resistance in patients with newly diagnosed tuberculosis","volume":"37","author":"Ginsburg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/598197","article-title":"Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective","volume":"48","author":"Low","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/jac\/dki353","article-title":"Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003","volume":"56","author":"Huang","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2010.02.002_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkm061","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure","volume":"59","author":"Wang","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2010.02.002_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/jac\/dkn096","article-title":"Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community","volume":"61","author":"Nathwani","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2010.02.002_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/519263","article-title":"Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin","volume":"45","author":"Gillet","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/RTI.0b013e318149e698","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: radiographic and computed tomography findings","volume":"23","author":"Nguyen","year":"2008","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.amjmed.2010.02.002_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jinf.2005.09.001","article-title":"The emergence of infections with community-associated methicillin resistant Staphylococcus aureus","volume":"52","author":"Diederen","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.amjmed.2010.02.002_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/427148","article-title":"Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes","volume":"40","author":"Francis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annemergmed.2008.04.027","article-title":"Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season","volume":"53","author":"Kallen","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib37","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1086\/429509","article-title":"Appropriate antimicrobial therapy for community-acquired methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes","volume":"40","author":"Wargo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib38","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"suppl 5","key":"10.1016\/j.amjmed.2010.02.002_bib39","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","article-title":"Pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"46","author":"Rubinstein","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib40","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2010.02.002_bib41","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl SC","key":"10.1016\/j.amjmed.2010.02.002_bib43","doi-asserted-by":"crossref","first-page":"4C","DOI":"10.1155\/2006\/971352","article-title":"Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners [published correction appears in Can J Infect Dis Med Microbiol. 2006;17:396]","volume":"17","author":"Barton","year":"2006","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.amjmed.2010.02.002_bib44","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","article-title":"Intrapulmonary pharmacokinetics of linezolid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2010.02.002_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003088-200847010-00003","article-title":"Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity","volume":"47","author":"Murthy","year":"2008","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 3","key":"10.1016\/j.amjmed.2010.02.002_bib46","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2010.02.002_bib47","unstructured":"Rubinstein E, Corey GR, Stryjewski ME, et al. Telavancin for hospital-acquired pneumonia, including ventilator-associated pneumonia: the ATTAIN studies. Presented at the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); April 19, 2008; Barcelona, Spain. Oral presentation O75."},{"key":"10.1016\/j.amjmed.2010.02.002_bib48","first-page":"2","article-title":"Improving clinical practice: MRSA case studies","author":"Moellering","year":"2009","journal-title":"MRSA"},{"key":"10.1016\/j.amjmed.2010.02.002_bib50","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/512436","article-title":"Performance measurement in community-acquired pneumonia: consequences intended and unintended","volume":"44","author":"File","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934310000975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:52:17Z","timestamp":1757580737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934310000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0002934310000975"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2010.02.002","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case Studies of Lower Respiratory Tract Infections: Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2010.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}